PRIOH-1, NCT03073967 / 2020-004940-27: Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects |
|
|
| Recruiting | 3 | 153 | Europe, Canada, US, RoW | Pritelivir, Investigator's choice, Foscarnet or Cidofovir or Imiquimod | AiCuris Anti-infective Cures AG, Medpace, Inc. | HSV Infection | 07/25 | 11/25 | | |
